Corporate GovernanceJun 12, 2026, 04:32 PM
INVO Fertility Amends 10-K, Details Executive Compensation
AI Summary
INVO Fertility, Inc. filed an amendment to its Form 10-K, primarily to remove the incorporation by reference of its definitive proxy statement for Part III and to include updated certifications for Item 15 of Part IV. The amendment does not contain financial statements. The filing also details executive and director compensation for 2025, including salary, bonuses, and stock awards. Notably, CEO Steven Shum experienced a late filing of a Form 4. The company's Audit Committee composition and financial expert designation are also outlined.
Key Highlights
- INVO Fertility amends Form 10-K to remove proxy statement incorporation by reference for Part III.
- Company adds currently dated certifications for Item 15 of Part IV.
- No financial statements are included in this Amendment.
- Steven Shum, CEO, had a late Form 4 filing on October 3, 2025, due to administrative issues.
- Audit Committee members are Szot (Chair), Messina, and Ryan; Szot is identified as an Audit Committee financial expert.
- Summary Compensation Table shows Steven Shum earned $430,863 in 2025, Terah Krigsvold $336,474, and Andrea Goren $282,530.
- Director Trent Davis earned $100,645 in 2025, Barbara Ryan $109,395, Matthew Szot $106,895, and Rebecca Messina $95,645.
Price Impact
More from IVF